Correlation Between Abcam PLC and In8bio
Can any of the company-specific risk be diversified away by investing in both Abcam PLC and In8bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcam PLC and In8bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcam PLC and In8bio Inc, you can compare the effects of market volatilities on Abcam PLC and In8bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcam PLC with a short position of In8bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcam PLC and In8bio.
Diversification Opportunities for Abcam PLC and In8bio
Average diversification
The 3 months correlation between Abcam and In8bio is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Abcam PLC and In8bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on In8bio Inc and Abcam PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcam PLC are associated (or correlated) with In8bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of In8bio Inc has no effect on the direction of Abcam PLC i.e., Abcam PLC and In8bio go up and down completely randomly.
Pair Corralation between Abcam PLC and In8bio
If you would invest 34.00 in In8bio Inc on September 5, 2024 and sell it today you would lose (2.00) from holding In8bio Inc or give up 5.88% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 1.59% |
Values | Daily Returns |
Abcam PLC vs. In8bio Inc
Performance |
Timeline |
Abcam PLC |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
In8bio Inc |
Abcam PLC and In8bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Abcam PLC and In8bio
The main advantage of trading using opposite Abcam PLC and In8bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcam PLC position performs unexpectedly, In8bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In8bio will offset losses from the drop in In8bio's long position.Abcam PLC vs. Anebulo Pharmaceuticals | Abcam PLC vs. Adagene | Abcam PLC vs. Acrivon Therapeutics, Common | Abcam PLC vs. AnaptysBio |
In8bio vs. Reviva Pharmaceuticals Holdings | In8bio vs. Cue Biopharma | In8bio vs. Lantern Pharma | In8bio vs. Anixa Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |